Washington, March 12 – The United States has become dangerously reliant on China for the raw materials and ingredients used in many of its most common medicines, lawmakers and expert witnesses warned at a Senate hearing, framing the issue as both a national security threat and an impending...
active pharmaceutical ingredients
arsenic
china
drug quality
generic drugs
medicines
national security
pharmaceuticals
public health
raw materials
rosemary gibson
senatecommitteeonaging
supply chain
ted yoho
thallium
united states
Washington, February 28 – A bipartisan US Senate panel criticized the Food and Drug Administration (FDA) for delays and shifting standards that witnesses said are hindering treatments for rare diseases, warning that “time is the most precious commodity” for families and that “patients with rare...
21st century cures act
accelerated approval pathway
clinical data
clinical trials
drug development
fda approval process
food and drug administration
orphan drug act
patient advocacy
pompe disease
rare diseases
real-world evidence
regulatory flexibility
senatecommitteeonaging
troriluzole